Pulmonx Corporation (LUNG) — Stock Score Summary

Pulmonx Corporation (LUNG) has a MoatMap StockRank of 19/100 based on Quality (35/100), Value (46/100), and Momentum (24/100) factor scores. The current signal is STRONG SELL. A small-cap medical device company with high cash burn and no established path to profitability, failing our quality compounder screen.

Pulmonx Corporation is a commercial-stage medical device company specializing in minimally invasive treatments for severe emphysema, a form of COPD. The company's flagship Zephyr Endobronchial Valve is a clinically proven, FDA-approved solution designed to improve lung function and quality of life without major surgery. Pulmonx holds a dominant market position in interventional pulmonology, supported by robust clinical evidence, global regulatory approvals, and established reimbursement pathways.

Key Financial Metrics

Price$1.52
Market Cap$71M
P/E (Forward)-1.55
Price/Book1.50
Return on Equity-86.2%
Return on Invested Capital-46.0%
Debt/Equity123.02
Gross Margin75.5%
Operating Margin-62.9%
Revenue Growth-8.7%
Free Cash Flow$-8M

Pulmonx Corporation operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Pulmonx Corporation’s (LUNG) StockRank?
MoatMap’s StockRank for Pulmonx Corporation (LUNG) is 19/100, with a Strong Sell signal. It is a composite of Quality (35), Value (46), and Momentum (24) factor ranks across MoatMap’s 19,000+ stock universe.
Does Pulmonx Corporation have an economic moat?
Pulmonx Corporation (LUNG) has a Quality factor score of 35/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Pulmonx Corporation a buy, hold, or sell?
MoatMap’s current signal for Pulmonx Corporation (LUNG) is Strong Sell, based on a StockRank of 19/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Pulmonx Corporation in?
Pulmonx Corporation (LUNG) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksLUNG deep dive reportAI ChampionsHow we score stocksSense-check another stock